Corcept Therapeutics Incorporated
CORT
$57.08
$5.9211.57%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -254.58% | -21.00% | -58.34% | -0.96% | -25.99% |
| Total Depreciation and Amortization | 29.44% | 4.78% | -4.41% | 136.87% | 158.10% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 41.43% | -58.19% | 1,672.20% | 97.02% | 99.26% |
| Change in Net Operating Assets | 123.35% | -49.27% | -87.85% | 15.01% | -205.83% |
| Cash from Operations | -451.61% | -35.98% | -25.67% | 6.68% | -79.92% |
| Capital Expenditure | -93.27% | 58.68% | 100.00% | 86.30% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 254.65% | 81.64% | 134.54% | 217.41% | 65.98% |
| Cash from Investing | 243.24% | 81.60% | 133.26% | 216.50% | 64.82% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 88.74% | 119.83% | 85.24% | 286.47% | 104.56% |
| Repurchase of Common Stock | 86.68% | -423.09% | -116.67% | -2,043.01% | -1,838.08% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 101.91% | -583.96% | -120.05% | -4,687.63% | -7,230.20% |
| Foreign Exchange rate Adjustments | -180.17% | 95.78% | -159.70% | 30,000.00% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 68.93% | 51.76% | 157.36% | 161.08% | -366.54% |